5 Lymphoma Clinical Trials in Richmond, VA (2026)

Q: How do I join a clinical trial in Richmond?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you.

Recruiting Lymphoma Studies in Richmond

NCT07691606Recruiting

A Study of ARC-02 in B-cell NHL

This study is to assess safety, tolerability, pharmacokinetics (PK), pharmacodynamic (PD), and preliminary efficacy of ARC-02....

Richmond, VAPHASE1140 participantsTaiho Oncology, Inc.

View Study Details

NCT06854653Recruiting

A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL

This is an open-label, phase 2 randomized study to evaluate the efficacy, safety, pharmacokinetics (PK) and pharmadynamics (PD), of PTX-100 monotherapy at 500 or 1000 mg/m2 in patients with relapsed/r...

Richmond, VAPHASE2115 participantsPrescient Therapeutics, Ltd.

View Study Details

NCT05595577Recruiting

Improving Exercise Capacity With a Tailored Physical Activity Intervention

The purpose of this research is to test whether participating in either a physical activity intervention or a series of educational classes will help to preserve exercise capability, heart function, b...

Richmond, VANA110 participantsWake Forest University Health Sciences

View Study Details

NCT06536049Recruiting

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

This phase Ib/II trial evaluates the safety, optimal dose, and efficacy of the combination of epcoritamab and ibrutinib in treating patients with aggressive B-cell non-Hodgkin lymphoma that has come b...

Richmond, VAPHASE138 participantsYazeed Sawalha

View Study Details

NCT06846463Recruiting

Zanubrutinib in Patients With DLBCL and MYD88 or NOTCH1 Mutation or CD5+

This study is a single-arm, open label, non-randomized, phase 2 trial of zanubrutinib in patients with diffuse large B-cell lymphoma (DLBCL) who have an MYD88 L265P mutation, a CD79B mutation, a NOTCH...

Richmond, VAPHASE221 participantsVirginia Commonwealth University

View Study Details

About Lymphoma Clinical Trials in Richmond

Lymphoma is a cancer of the lymphatic system that affects infection-fighting cells called lymphocytes. The two main types are Hodgkin lymphoma and non-Hodgkin lymphoma. Treatment often includes chemotherapy, radiation, immunotherapy, and in some cases stem cell transplant.

There are currently 5 lymphoma clinical trials recruiting participants in Richmond, VA. These studies are seeking a combined 424 participants. Research is being sponsored by Taiho Oncology, Inc., Prescient Therapeutics, Ltd., Wake Forest University Health Sciences and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Lymphoma Clinical Trials in Richmond — FAQ

Are there lymphoma clinical trials in Richmond?

Yes, there are 5 lymphoma clinical trials currently recruiting in Richmond, VA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Richmond?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Richmond research site will contact you about next steps.

Are clinical trials in Richmond free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Richmond studies also compensate for your time and travel.

What lymphoma treatments are being tested?

The 5 active trials in Richmond are testing new therapies including novel drugs, biologics, and treatment approaches for lymphoma.

Data updated September 2, 2026 from ClinicalTrials.gov